The efficacy of monthly administration o
โ
Khalid Alsaran; Alaa Sabry; Mamdouh Abdulghafour; Mohammad Hji
๐
Article
๐
2009
๐
Wiley (John Wiley & Sons)
๐
English
โ 344 KB
BACKGROUND: Erythropoiesis-stimulating agents have improved the outcome and quality of life in patients with chronic kidney disease. OBJECTIVE: We investigated the effi cacy and safety of conversion of hemodialysis patients from epoetin beta to darbepoetin alfa administered once a month. ## PATIENT